Journal
RSC ADVANCES
Volume 5, Issue 20, Pages 15453-15460Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c4ra16544f
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81272453, 81472850]
- 973 Program [2010CB93404]
Ask authors/readers for more resources
Co-delivery is a feasible means to overcome the drawbacks of using a single drug. Herein, we report novel polymer nanoparticles based on branched polyethyleneimine and palmitic acid conjugates for bortezomib and paclitaxel co-delivery. These drug-loaded nanoparticles have a preferable particle size, high encapsulation efficiency and a pH-dependent release profile. The co-delivery system has a great advantage in suppressing tumor cell growth over single drug loaded nanoparticles, whereas the polymer nanocarrier itself shows excellent biocompatibility. The good cellular uptake properties and synergistic effects of co-delivery by polymer nanoparticles provide significant advances toward cancer therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available